HIGHLIGHTS
- who: Marion Lassalle from the Saint-Denis, France have published the paper: Use of proton pump inhibitors in adults in France: a nationwide drug utilization study, in the Journal: (JOURNAL) of December/31,/2015
- what: The aim of this study was to describe outpatient PPI use of the whole adult population in France based on the French National Health Data System (SNDS).
SUMMARY
PPIs are approved in the following main indications: treatment of gastroesophageal reflux disease (GERD) and reflux esophagitis, treatment of nonsteroidal anti-inflammatory drugs (NSAID)-associated gastrointestinal (GI) lesions . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.